When did Profound Medical report Q4 2024 earnings?

Profound Medical (PROF) reported Q4 2024 earnings on March 6, 2025 after market close.

What were Profound Medical's Q4 2024 revenue and EPS?

Profound Medical reported revenue of $5.3M and eps of $-0.20 for Q4 2024.

Did Profound Medical beat estimates in Q4 2024?

Revenue missed the consensus estimate of $5.9M by $591.4K. EPS beat the consensus estimate of $-0.31 by $0.11.

Where can I find Profound Medical's Q4 2024 SEC filings?

You can read the 10-K periodic report (0001410578-25-000300) directly on SEC EDGAR. The filing index links above go to sec.gov.

Profound Medical PROF Q4 2024 Annual earnings

Reported March 6, 2025 · After market close

Revenue$5.3MMiss by $591.4K

EPS-$0.20Beat by $0.11

Revenue estimate$5.9M

EPS estimate-$0.31

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$4.8M

EPS estimate-$0.22

Financials

Q4 2024

Income statement

See full

Revenue$4.2M+132%

Gross profit$3.0M+175%

Operating income-$8.3M-16.5%

Net income-$4.9M+30.1%

EPS (diluted)$0.18-46.3%

Balance sheet

See full

Cash & equivalents$54.9M+109%

Total debt$5.1M-34.9%

Total equity$60.4M+93.5%

Total assets$70.2M+59.8%

Cash flow

See full

Operating cash flow-$5.9M-4.0%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$225.51M+24.3%

Enterprise value$175.72M+7.8%

P/S21.1×-4.1×

Profitability

See full

Gross margin65.9%+6.0pp

Operating margin-309.6%-56.3pp

Net margin-260.4%-65.8pp

Returns & leverage

See full

Return on equity-60.7%-5.6pp

Debt / equity0.1×-0.2×

Current ratio10.5×+3.9×

Segments

By geography

See full

US$2.9M+125%

CA$1.1M+1,891%

DE$152.0K-67.0%

By product

See full

Recurring Non Capital$2.7M+58.0%

Capital Equipment$1.5M+1,415%

Versus estimates

Revenue

Q1 2026$5.3MBeat by $485.0K Q4 2025$6.0MMiss by $1.7M Q3 2025$5.2MMiss by $5.3M Q2 2025$2.2MMiss by $2.5M Q1 2025$2.6MMiss by $2.1M

Q4 2024$5.3MMiss by $591.4K

Diluted EPS

Q1 2026-$0.19Beat by $0.05 Q4 2025-$0.27In line Q3 2025-$0.26Beat by $0.12 Q2 2025-$0.52Miss by $0.09 Q1 2025-$0.36Miss by $0.07

Q4 2024-$0.20Beat by $0.11

Ask the moment Profound Medical reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Profound Medical report Q4 2024 earnings?: Profound Medical (PROF) reported Q4 2024 earnings on March 6, 2025 after market close.
What were Profound Medical's Q4 2024 revenue and EPS?: Profound Medical reported revenue of $5.3M and eps of $-0.20 for Q4 2024.
Did Profound Medical beat estimates in Q4 2024?: Revenue missed the consensus estimate of $5.9M by $591.4K. EPS beat the consensus estimate of $-0.31 by $0.11.
Where can I find Profound Medical's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001410578-25-000300) directly on SEC EDGAR. The filing index links above go to sec.gov.